학술논문
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer
Document Type
Article
Author
Leboulleux, S.; Terroir-Cassou-Mounat, M.; Anizan, N.; Lamartina, L.; Schlumberger, M.; Do Cao, C.; Zerdoud, S.; Attard, M.; Bournaud, C.; Lacroix, L.; Al Ghuzlan, A.; Benisvy, D.; Schiazza, A.; Taïeb, D.; Garcia, M.-E.; Bardet, S.; Ciappuccini, R.; Bouvier-Morel, E.; Borget, I.; Lion, G.; Betrian, S.; Sajous, C.; Godbert, Y.
Source
In: Clinical cancer research : an official journal of the American Association for Cancer Research . (Clinical cancer research : an official journal of the American Association for Cancer Research, 5 July 2023, 29(13):2401-2409)
Subject
Language
English
ISSN
15573265